CHELA-FER® Syrup — Reduces Tiredness with Ferrous Bisglycinate
This liquid hematinic formulation provides highly bioavailable iron bisglycinate chelate combined with folic acid to optimise red blood cell synthesis and oxygen transport. The chelation organic amino acid carrier bypasses typical gastrointestinal degradation, facilitating advanced mucosal absorption without causing significant gastric irritation. By restoring systemic iron stores, it actively mitigates fatigue and supports cellular energy metabolism in both adults and paediatric patients.
Recommended Usage
Adults and children 14 years and older: Take one and a half medicine measure (7.5 ml) once daily after meals, or as directed by your healthcare practitioner.
Children 2-13 years old: Take one medicine measure (5 ml) once daily after meals, or as directed by your healthcare practitioner.
Composition
| Serving size : 7.5 ml | Amount per serving |
| Iron (elemental) from Ferrochel™ ferrous bisglycinate chelate 75.0 mg | 15mg |
| Folic acid | 200mcg |
Other Ingredients
Methylparaben, polysorbate 80, purified water, sorbitol, sucrose and tutti-frutti flavouring
Contains sugar: sucrose 0.12 g/5 ml
Contains sweetener: sorbitol 2.45 g/5 ml
Preservative: methylparaben 0.2 % m/v
Does Not Contain
Suitable for vegans and vegetarians
Storage
Store in a cool dry place (<25°C), away from sunlight. Keep out of reach of children.
Product Form
Syrup
Warnings/Contraindication
If pregnant, nursing or taking medication, consult your healthcare practitioner before use.
Do not use this product if you have an allergy or sensitivity to any of the ingredients.
Do not administer CHELA-FER® concomitantly with parenteral iron.
CHELA-FER® should not be given to patients with anaemias not produced by iron deficiency.
Recommended dosage(s) should not be exceeded unless on the advice of a healthcare practitioner.
Contains sucrose. Patients with rare hereditary conditions such as fructose intolerance, glucose - galactose mal-absorption or sucrase isomaltase insufficiency should not take CHELA-FER®.
Patients with the rare hereditary condition of sorbitol intolerance should not take CHELA-FER®.
CHELA-FER® syrup contains sucrose which may have an effect on the glycaemic control of patients with diabetes mellitus.
Please review package insert (if available) for further information.



